Hospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2019

  1. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

    Kidney International, Vol. 96, Núm. 4, pp. 995-1004

2013

  1. Early-onset anemia after kidney transplantation is an independent factor for graft loss: A multicenter, observational cohort study

    Transplantation, Vol. 96, Núm. 8, pp. 717-725

  2. Once-monthly pegylated epoetin beta versus darbepoetin alfa every two weeks in renal transplant recipients: A randomized Trial

    Transplantation

2012

  1. Avances en la inmunosupresión para el trasplante renal. Nuevas estrategias para preservar la función renal y reducir el riesgo cardiovascular

    Nefrologia, Vol. 32, Núm. 3, pp. 374-384

  2. Risk factors for graft loss and mortality after renal transplantation according to recipient age: A prospective multicentre study

    Nephrology Dialysis Transplantation, Vol. 27, Núm. SUPPL.4

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

2008

  1. Recomendaciones para la indicación, obtención, procesamiento y evaluación de biopsias en el trasplante renal

    Nefrologia, Vol. 28, Núm. 4, pp. 385-396

  2. Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease

    Kidney International

2002

  1. Prevention of cardiovascular risk in renal transplantation. Consensus document

    Nefrología : publicación oficial de la Sociedad Española Nefrologia

1997

  1. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain

    Transplantation, Vol. 63, Núm. 9, pp. 1278-1286